DOI: 10.1055/s-00000041

Neuropediatrics

References

Aartsma-Rus A.
FDA approval of nusinersen for spinal muscular atrophy makes 2016 the year of splice modulating oligonucleotides.

Nucleic Acid Ther 2017;
27 (02) 67-69

Download Bibliographical Data

Access:
Access: